Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors

ABSTRACT Dendritic cells (DCs) initiate adaptive immune responses after their migration to secondary lymphoid organs. The LXR ligands/oxysterols and the RXR ligand 9-cis Retinoic Acid (9-cis RA) were shown to dampen DC migration to lymphoid organs through the inhibition of CCR7 expression. We performed transcriptomics of DCs undergoing maturation in the presence of the LXR ligand 22R-Hydroxycholesterol (22R-HC). The analysis highlighted more than 1500 genes modulated by 22R-HC treatment, including the triggering receptor expressed on myeloid cells (TREM)-1, which was found markedly up-regulated. We tested the effect of other nuclear receptor ligands (NRL) and we reported the induction of TREM-1 following RXR, RAR and VDR activation. From a functional point of view, triggering of TREM-1 induced by retinoids increased TNFα and IL-1β release, suggesting an active role of NRL-activated TREM-1+ DCs in inflammation-driven diseases, including cancer. Consistently with this hypothesis we detected DCs expressing TREM-1 in pleural effusions and ascites of cancer patients, an observation validated by the induction of TREM-1, LXR and RAR target genes when monocyte-DCs were activated in the presence of tumor-conditioned fluids. Finally, we observed a better control of LLC tumor growth in Trem-1−/- bone marrow chimera mice as compared to wild type chimera mice. Future studies will be necessary to shed light on the mechanism of TREM-1 induction by distinct NRL, and to characterize the role of TREM-1+ DCs in tumor growth.

[1]  M. Karin,et al.  NF-κB, inflammation, immunity and cancer: coming of age , 2018, Nature Reviews Immunology.

[2]  P. Krebs,et al.  TREM-1 promotes intestinal tumorigenesis , 2017, Scientific Reports.

[3]  M. Dessing,et al.  TREM‐1 and its potential ligands in non‐infectious diseases: from biology to clinical perspectives , 2017, Pharmacology & therapeutics.

[4]  Y. Saeys,et al.  TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine , 2017, Nature Communications.

[5]  T. Yun,et al.  The Importance of Dendritic Cells in Maintaining Immune Tolerance , 2017, The Journal of Immunology.

[6]  A. Saghatelian,et al.  SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. , 2017, Cell metabolism.

[7]  A. Valledor,et al.  The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism. , 2017, Cell reports.

[8]  R. Förster,et al.  Dendritic cell migration in health and disease , 2016, Nature Reviews Immunology.

[9]  J. Austyn.  Dendritic Cells in the Immune System—History, Lineages, Tissues, Tolerance, and Immunity , 2016, Microbiology spectrum.

[10]  C. Simillion,et al.  TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis , 2016, Nature Communications.

[11]  C. Doglioni,et al.  The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice , 2016, Cancer Immunology, Immunotherapy.

[12]  E. Gratton,et al.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.

[13]  D. Agrawal,et al.  Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells , 2015, Expert review of clinical immunology.

[14]  John Vu,et al.  Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity , 2015, eLife.

[15]  B. Pulendran.  The varieties of immunological experience: of pathogens, stress, and dendritic cells. , 2015, Annual review of immunology.

[16]  Jeffrey L. Dantzler,et al.  Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1 , 2015, The Journal of Immunology.

[17]  D. Maggioni,et al.  Cholesterol metabolites and tumor microenvironment: the road towards clinical translation , 2015, Cancer Immunology, Immunotherapy.

[18]  Chirayu Pankaj Goswami,et al.  PROGgeneV2: enhancements on the existing database , 2014, BMC Cancer.

[19]  R. Evans,et al.  Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.

[20]  S. A. van de Pavert,et al.  Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity , 2014, Nature.

[21]  Renato Ostuni,et al.  Lineages, cell types and functional states: a genomic view. , 2013, Current opinion in cell biology.

[22]  Guang-xiu Lu,et al.  TREM-1 inhibition attenuates inflammation and tumor within the colon. , 2013, International immunopharmacology.

[23]  J. Gustafsson,et al.  The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils , 2013, The Journal of experimental medicine.

[24]  Y. Lee,et al.  Regulation of TREM-1 expression by 1,25-dihydroxyvitamin D3 in human monocytes/macrophages. , 2013, Immunology letters.

[25]  V. Soumelis,et al.  Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.

[26]  E. Villablanca.  Retinoic acid-producing DCs and gut-tropic FOXP3+ regulatory T cells in the induction of oral tolerance , 2013, Oncoimmunology.

[27]  G. Trinchieri,et al.  The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. , 2012, Cancer Research.

[28]  S. Qiu,et al.  Expression of TREM‐1 in hepatic stellate cells and prognostic value in hepatitis B‐related hepatocellular carcinoma , 2012, Cancer science.

[29]  S. Heikkinen,et al.  Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages , 2012, BMC Genomics.

[30]  H. Weiner,et al.  Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice. , 2011, Gastroenterology.

[31]  Y. Belkaid,et al.  The role of retinoic acid in tolerance and immunity. , 2011, Immunity.

[32]  F. Novelli,et al.  Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. , 2011, Blood.

[33]  E. Devilard,et al.  Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. , 2010, Blood.

[34]  Sandro Sonnino,et al.  Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses , 2010, Nature Medicine.

[35]  Peter Tontonoz,et al.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. , 2009, Immunity.

[36]  M. Rescigno,et al.  Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells , 2009, Gut.

[37]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[38]  J. Gustafsson,et al.  GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. , 2009, Molecular cell.

[39]  L. Nagy,et al.  1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype12 , 2009, The Journal of Immunology.

[40]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[41]  Hsuan-Yu Chen,et al.  TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. , 2008, American journal of respiratory and critical care medicine.

[42]  M. Colonna,et al.  Uncovering the TREM-1-TLR connection. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[43]  F. Seibold,et al.  TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. , 2007, The Journal of clinical investigation.

[44]  T. Willson,et al.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. , 2007, Molecular cell.

[45]  L. Adorini,et al.  1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells1 , 2007, The Journal of Immunology.

[46]  M. Colonna,et al.  The TREM receptor family and signal integration , 2006, Nature Immunology.

[47]  M. Colonna,et al.  Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine1 , 2005, The Journal of Immunology.

[48]  Peter Tontonoz,et al.  Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.

[49]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[50]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[51]  D. Peet,et al.  The LXRs: a new class of oxysterol receptors. , 1998, Current opinion in genetics & development.